분자유전학실험실 (단국대학교 분자생물학과)

 이성욱 ( 2017-07-25 19:37:17 , Hit : 919
 Engineered Human Liver Tissue Grows in Mice


The Scientist »
News & Opinion »
Daily News

Tissue “seeds” made up of three cell types and patterned onto a scaffold develop into complex structures with some organ function, researchers show.

By Anna Azvolinsky | July 19, 2017

Engineering human livers is a lofty goal. Human liver cells, hepatocytes, are particularly difficult to grow in the laboratory as they lose liver functions quickly in a dish. Now, in a study published today (July 19) in Science Translational Medicine, researchers show that a “seed” of human hepatocytes and supporting cells assembled and patterned within a scaffold can grow out to 50 times its original size when implanted into mice.

These engineered livers, which begin to resemble the natural structure of the organ, offer an approach to study organ development and as a potential strategy for organ engineering.

“What blew my mind is that when we implant these tissues into a mouse with liver injury, the tissue seeds just blossom,” says study author Kelly Stevens, who conducted the experiments as a postdoc in Sangeeta Bhatia’s lab at MIT and now runs her own bioengineering lab at the University of Washington. “Nature takes over and self-assembles a structure that looks like a human liver and has many liver-associated functions.”

“This is a very exciting approach and another demonstration that we can build a basic liver unit using three basic cell types,” says Tammy Chang, an assistant professor of surgery at the University of California, San Francisco, who studies liver tissue regeneration and was not involved in the latest work.

In 2011, Bhatia's lab showed that human liver-cell aggregates could be grown in mice. She and her colleagues assembled human hepatocytes and supportive stromal cells within a polymer scaffold, demonstrating that this dime-size artificial human liver tissue could grow stably for weeks in immune-compromised mice that had their own normal livers. The liver implant, the researchers found, fused with the mouse circulatory system and received blood to perform a few liver functions.

See “The Organist”

In the new work, the lab wanted to expand the size of the human liver graft beyond the 1 million cells used in the prior model. The team assembled different geometries of human primary hepatocytes, human umbilical vein endothelial cells, and fibroblasts, placed them within a degradable hydrogel, and implanted the tissue seed into a fat pad within a liver-injury mouse model.

To recapitulate liver damage, the animals are missing a key amino acid metabolism gene that results in toxic metabolite build up and progressive liver failure, which can be rescued by a drug used to treat individuals with a similar genetic disorder. Stevens says her group chose this model because it they expected it to foster the liver seeds’ growth. “The hypothesis is that mouse liver injury will produce factors that will travel through the blood stream and tell the human liver tissue to regenerate,” explains Stevens.  

The team found that the human liver tissue grew less in animals that were continuously treated with the drug compared to animals that were given intermittent cycles of the small molecule.

The human liver seed tissue grew best, the researchers found, when they assembled endothelial cells into rope-like structures on top of the hepatocytes, rather than when the tissue was a spherical aggregate of all three cell types. The patterned tissue formed new structures in vivo, including ones that resembled bile ducts, and contained pockets of red blood cells, suggesting the presence of vascular structures within the tissue. The organ-like structures also produced appropriate human proteins such as albumin and transferrin.

“These results clearly suggest that the geometric design of a transplant graft is an important consideration for [organ engineering], at least for an ectopic implantation approach,” Takanori Takabe, whose lab at Yokohama City University in Japan is developing organs from stem cells and who was not part of the study, writes in an email to The Scientist.

See “Orchestrating Organoids”

Researchers have been using stem cells to make organoids in a dish, miniature three-dimensional cell clusters, which are used to study the biology and formation of organs.

“At the moment, it is a great and unique research tool to understand liver growth,” Eric Lagasse, who works on stem cells and organogenesis at the University of Pittsburgh and was not involved in the study, writes in an email to The Scientist.

For Chang, a major question is what is special about this liver injury model. “The robust growth of the liver tissue here may be unique to this form of livery injury and it would be interesting now to understand the factors that promote regeneration and growth of these liver tissue aggregates,” she says.

And, of course, there’s the question of utility in humans, notes Stevens. “Could we eventually get this to the level where it can be transplanted into patients to provide them with some liver function?”

K. R. Stevens et al., “In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease,” Science Translational Medicine, doi:10.1126/scitranslmed.aah5505, 2017.  

1207   Cancer Onset May Be Caused by Immune System Fighting Viruses  이성욱 2017/08/25 860
1206   Resistance to HIV Engineered Via CRISPR  이성욱 2017/08/07 868
1205   Zika Update  이성욱 2016/03/15 870
1204   [바이오토픽] 드디어 올 것이 왔다: CRISPR, 생존가능 인간배아의 질병초래 유전자 교정 성공  이성욱 2017/08/03 876
1203   CRISPR Corrects RNA-based Disease Defects  이성욱 2017/08/14 877
1202   [바이오토픽] 중국, 최초의 유전체편집 아기 탄생  이성욱 2018/11/27 877
1201   “유전자 치료 법률 금지 한국 유일” vs “생명체 설계도 바꾸는 건 문제”  이성욱 2017/08/28 880
1200   CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect  이성욱 2016/02/01 893
1199   First In Vivo Human Genome Editing to Be Tested in New Clinical Trial  이성욱 2017/05/18 894
1198   [바이오토픽] FDA 자문위원회, CAR-T(chimeric antigen receptor T cell) 승인 만장일치로 권고  이성욱 2017/07/14 907
1197   유전자치료제 '인보사' 연골재생 입증못해도 허가받은 까닭  이성욱 2017/07/14 909
1196   ‘단세포 인공생명체’ 눈앞에 성큼  이성욱 2017/03/11 910
1195   Revisiting CAR T-Cells for Treating HIV Shows Promise  이성욱 2016/07/19 916
1194   CRISPR Can Tag RNA  이성욱 2016/03/26 917
  Engineered Human Liver Tissue Grows in Mice  이성욱 2017/07/25 919
1192   RNA May Surpass DNA in Precision Medicine  이성욱 2016/03/23 922
1191   독감바이러스의 ‘RNA 도둑질’  이성욱 2017/05/08 922
1190   노벨 생리의학상 유감(有感)  이성욱 2015/10/06 924
1189   Editas Expands CRISPR Capabilities through New Technology Licensing  이성욱 2016/12/22 926
1188   Using Gene Editing to Delete HIV from Human T Cells  이성욱 2016/03/23 928

[1][2][3] 4 [5][6][7][8][9][10]..[64] [다음 10개]

Copyright 1999-2024 Zeroboard / skin by ROBIN